Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: Comparison with patients with MAPT and no known mutations

Brain

Volumn 131, Issue 3, 2008, Pages 721-731

  Pickering Brown, Stuart M ^a   Rollinson, Sara ^a   Du Plessis, Daniel ^b   Morrison, Karen E ^c,d   Varma, Anoop ^a,b   Richardson, Anna M T ^a,b   Neary, David ^a,b   Snowden, Julie S ^a,b   Mann, David M A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Apraxia; Frontotemporal dementia; Genetics; MAPT; Progranulin; Progressive non fluent aphasia; Tau

Indexed keywords

PROGRANULIN;

ADULT; AGED; ALLELE; APHASIA; APRAXIA; ARTICLE; BEHAVIOR DISORDER; BRAIN DEGENERATION; CADAVER; CLINICAL FEATURE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; EXON; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MAPT GENE; MEDICAL ASSESSMENT; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGRANULIN GENE; SEX RATIO; STOP CODON;

EID: 39749187585     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm331     Document Type: Article

References (70)

1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-11.
2. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8: 711-5.
3. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-9.
4. Behrens MI, Mukherjee O, Tu PH, Liscic RM, Grinberg LT, Carter D, et al. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord 2007; 21: 1-7.
5. Benussi L, Binetti G, Sina E, Gigola L, Bettecken T, Meitinger T, et al. A noveldeletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2006 (accession number 17157414).
6. Bergmann M, Kuchelmeister K, Schmid KW, Kretzschmar HA, Schroder R. Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol 1996; 92: 170-9.
7. Boeve BF, Baker M, Dickson DW, Parisi JE, Giannini C, Josephs KA, et al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. Brain 2006; 129: 3103-14.
8. Bronner IF, Rizzu P, Seelaar H, van Mil SE, Anar B, Azmani A, et al. Progranulin mutations in Dutch familial frontotemporal lobar degeneration. Eur J Hum Genet 2007; 15: 369-74.
9. Brooks B, Miller R, Swash M, Munsat L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-9.
10. Chow TW, Miller BL, Hayashi VN, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56: 817-22.
11. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-4.
12. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 2007; 113: 521-33.
13. Davion S, Johnson N, Weintraub S, Mesulam M-M, Engberg A, Mishra M, et al. Clinicopathologic correlation in PGRN mutations. Neurology 2007; 69: 1113-21.
14. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-62.
15. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
16. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006; 15: 2988-3001.
17. Groups TLaM. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-8.
18. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
19. Huey ED, Grafman J, Wassermann EM, Pietrini P, Tierney MC, Ghetti B, et al. Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann Neurol 2006; 60: 374-80.
20. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′ splice site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5.
21. Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, et al. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology 2002; 58: 1161-8.
22. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007; 66: 142-51.
23. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30: 369-73.
24. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, Puel M, et al. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 2007; 28: 846-55.
25. Leverenz JB, Yu CE, Montine TJ, Steinbart E, Bekris LM, Zabetian C, et al. A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain 2007; 130: 1360-74.
26. Lipton AM, White CL III, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol 2004; 108: 379-85.
27. Mackenzie IR, Baborie A, Pickering-Brown S, Plessis DD, Jaros E, Perry RH, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 2006a; 112: 539-49.
28. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006b; 129: 3081-90.
29. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 2006c; 129: 853-67.
30. Mackenzie IR, Feldman H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Acta Neuropathol 2003; 105: 543-8.
31. Mackenzie IR, Shi J, Shaw CL, Duplessis D, Neary D, Snowden JS, et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 2006d; 112: 551-9.
32. Masellis M, Momeni P, Meschino W, Heffner R Jr, Elder J, Sato C, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006; 129: 3115-23.
33. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol 2007; 64: 43-7.
34. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006; 66: 839-44.
35. Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VM, Forman M, et al. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol 2005; 64: 420-8.
36. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 2006; 60: 314-22.
37. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005; 4: 771-80.
38. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
39. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
40. Pickering-Brown S, Baker M, Bird T, Trojanowski J, Lee V, Morris H, et al. Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation. Am J Med Genet 2004; 125B: 79-82.
41. Pickering-Brown SM. Progranulin and frontotemporal lobar degeneration. Acta Neuropathol 2007a; 114: 39-47.
42. Pickering-Brown SM. The complex aetiology of frontotemporal lobar degeneration. Exp Neurol 2007b; 206: 1-10.
43. Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain 2006; 129: 3124-6.
44. Pickering-Brown SM, Richardson AM, Snowden JS, McDonagh AM, Burns A, Braude W, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 2002; 125: 732-51.
45. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001; 58: 383-7.
46. Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C->T (Arg493X) mutation: an international initiative. Lancet Neurol 2007; 6: 857-68.
47. Rizzu P, van Mil SE, Anar B, Rosso SM, Kaat LD, Heutink P, et al. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 944-6.
48. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999; 64: 414-21.
49. Rollinson S, Snowden JS, Neary D, Morrison KE, Mann DM, Pickering-Brown SM. TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett 2007; 419: 1-4.
50. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 2001; 124: 1948-57.
51. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006; 169: 1343-52.
52. Schumacher A, Friedrich P, Diehl-Schmid J, Ibach B, Eisele T, Laws SM, et al. No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiol Aging 2007; 28: 1789-90.
53. Seelaar H, Jurgen Schelhaas H, Azmani A, Kusters B, Rosso S, Majoor-Krakauer D, et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations. Brain 2007; 130: 1375-85.
54. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59: 97-105.
55. Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol 2005; 110: 501-12.
56. Shiarli AM, Jennings R, Shi J, Bailey K, Davidson Y, Tian J, et al. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropath Appl Neurobiol 2006; 32: 374-87.
57. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-8.
58. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007; 114: 31-8.
59. Snowden JS, Neary D. Progressive anomia with preserved oral spelling and automatic speech. Neurocase 2003; 9: 27-43.
60. Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain 2006; 129: 3091-102.
61. Spina S, Murrell JR, Huey ED, Wassermann EM, Pietrini P, Baraibar MA, et al. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology 2007; 68: 820-7.
62. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-9.
63. Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 2007; 113: 535-42.
64. Taniguchi S, McDonagh AM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, et al. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol 2004; 30: 1-18.
65. van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, Camuzat A, et al. Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 2007; 28: 416.
66. van der Zee J, Rademakers R, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 2006; 129: 841-52.
67. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 2006; 129: 868-76.
68. Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 2004; 61: 398-406.
69. Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol 2001; 102: 94-102.
70. Xiao S, Sato C, Kawarai T, Goodall EF, Pall HS, Zinman LH, et al. Genetic studies of GRN and IFT74 in amyotrophic lateral sclerosis. Neurobiol Aging 2007 (accession number 17383054).